Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Am J Ophthalmol. 2013 Sep 28;157(2):301–310.e1. doi: 10.1016/j.ajo.2013.09.024

Table 2.

Demographics of each tear dysfunction group and the control group.

Groups N (eyes) N (subjects) Age-mean (years) Age-range (years) Male-to-female ratio
All subjects 128 64 56 19-87 0.37
All Tear Dysfunction 68 34 60 25-87 0.13

MGDa 23 13 57 25-85 0.18
ATDb 41 21 65 31-87 0.14
SSATDc 17 9 64 31-76 0.29
non-SSATDd 16 10 65 49-87 0.10

All controls 33 20 51 19-82 2.17
    Controls ≥ 50 years 17 12 65 50-82 1.40
    Controls < 50 years 16 8 22 19-27 3.00
a

MGD: meibomian gland disease

b

ATD: aqueous tear deficiency

c

SSATD: Sjögren syndrome aqueous tear deficiency

d

non-SSATD: non- Sjögren syndrome aqueous tear deficiency